Lung valve aims to release trapped air in severe emphysema

NCT ID NCT07097896

Recruiting now Disease control Sponsor: China-Japan Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests a silicone valve placed in the airways to reduce overinflated parts of the lung in people with severe emphysema. The valve lets trapped air escape, which may improve breathing and daily function. Participants receive either the valve plus standard care or standard care alone. The study measures changes in lung function and quality of life over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: endobronchial silicone valve
What this could lead to: If it works, this could offer a new, less invasive option to improve breathing and quality of life for people with severe emphysema.
What could go wrong: This is a relatively small trial, and the valve may not work for everyone. Risks include infection, valve movement, or worsening breathing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMPHYSEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease pulmonary emphysema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EMPHYSEMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100029, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.